Connect Biopharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.

About CNTB

Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. 

CEO
Zheng Wei
CEOZheng Wei
Employees
Employees
Headquarters
Taicang, Jiangsu
HeadquartersTaicang, Jiangsu
Founded
2015
Founded2015
Employees
Employees

CNTB Key Statistics

Market cap
39.76M
Market cap39.76M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
31.70K
Average volume31.70K
High today
$0.7372
High today$0.7372
Low today
$0.69
Low today$0.69
Open price
$0.7218
Open price$0.7218
Volume
68.55K
Volume68.55K
52 Week high
$5.99
52 Week high$5.99
52 Week low
$0.5573
52 Week low$0.5573

CNTB Earnings

Q1 FY21
Q2 FY21
Q3 FY21
Estimated
per share
Estimated per share
Actual
Expected Mar 30, After Hours
ActualExpected Mar 30, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.